382 related articles for article (PubMed ID: 19550293)
1. Smac mimetics as new cancer therapeutics.
Chen DJ; Huerta S
Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells.
Abe S; Hasegawa M; Yamamoto K; Kurata M; Nakagawa Y; Suzuki K; Takizawa T; Kitagawa M
Exp Mol Pathol; 2007 Dec; 83(3):405-12. PubMed ID: 17521628
[TBL] [Abstract][Full Text] [Related]
4. [Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways].
Korga A; Korobowicz E; Dudka J
Pol Merkur Lekarski; 2006 May; 20(119):573-6. PubMed ID: 16875166
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity.
Vogler M; Giagkousiklidis S; Genze F; Gschwend JE; Debatin KM; Fulda S
Oncogene; 2005 Nov; 24(48):7190-202. PubMed ID: 16091752
[TBL] [Abstract][Full Text] [Related]
6. Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
[TBL] [Abstract][Full Text] [Related]
7. Smac mimetics as IAP antagonists.
Fulda S
Semin Cell Dev Biol; 2015 Mar; 39():132-8. PubMed ID: 25550219
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
[TBL] [Abstract][Full Text] [Related]
9. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
10. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design of potent, conformationally constrained Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Xu L; Liu M; Tomita Y; Pan H; Yoshioka Y; Krajewski K; Roller PP; Wang S
J Am Chem Soc; 2004 Dec; 126(51):16686-7. PubMed ID: 15612682
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: targeting death receptors and smac mimetics.
Fulda S
Clin Cancer Res; 2014 Aug; 20(15):3915-20. PubMed ID: 24824309
[TBL] [Abstract][Full Text] [Related]
14. Impaired kinetics of Bax-GFP and Smac/DIABLO-GFP in caspase-8- and bid-silenced and Bcl-2 overexpressed breast cancer MCF-7 cells exposed to camptothecin.
Górka M; Lamparska-Przybysz M; Motyl T
Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL915-22. PubMed ID: 17666167
[TBL] [Abstract][Full Text] [Related]
15. Smac/DIABLO is required for effector caspase activation during apoptosis in human cells.
Rajalingam K; Oswald M; Gottschalk K; Rudel T
Apoptosis; 2007 Aug; 12(8):1503-10. PubMed ID: 17440818
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein recognition as a first step towards the inhibition of XIAP and Survivin anti-apoptotic proteins.
Obiol-Pardo C; Granadino-Roldán JM; Rubio-Martinez J
J Mol Recognit; 2008; 21(3):190-204. PubMed ID: 18438971
[TBL] [Abstract][Full Text] [Related]
17. IAP proteins: sticking it to Smac.
Duckett CS
Biochem J; 2005 Jan; 385(Pt 1):e1-2. PubMed ID: 15588250
[TBL] [Abstract][Full Text] [Related]
18. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
Sun Q; Zheng X; Zhang L; Yu J
Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
[TBL] [Abstract][Full Text] [Related]
19. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
Ali R; Singh S; Haq W
Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
[TBL] [Abstract][Full Text] [Related]
20. Promises and Challenges of Smac Mimetics as Cancer Therapeutics.
Fulda S
Clin Cancer Res; 2015 Nov; 21(22):5030-6. PubMed ID: 26567362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
